JCI InsightNeurosciencePeer-reviewed journal article
Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling
Nydia P. Chang, Evan M. DaPranoiD, Marissa LindmaniD, Irving EsteveziD, Tsui-Wen ChouiD, Wesley R. EvansiD, Marialaina Nissenbaum, Micheal McCourt, Diego Alzate, Colm AtkinsiD, Alexander W. KusnecoviD, Rafiq HudaiD, Brian P. DanielsiD
Abstract
Astrocyte activation is a common feature of neurodegenerative diseases. However, the ways in which dying neurons influence the activity of astrocytes is poorly understood. RIPK3 signaling has recently been described as a key regulator of neuroinflammation, but whether this kinase mediates astrocytic responsiveness to neuronal death has not yet been studied. Here, we used the MPTP model of Parkinsons disease to show that activation of astrocytic RIPK3 drives dopaminergic cell death and axon damage. Transcriptomic profiling revealed that astrocytic RIPK3 promoted gene expression associated with neuroinflammation and movement disorders, and this coincided with significant engagement of DAMP signaling. Using human cell culture systems, we show that factors released from dying neurons signal through RAGE to induce RIPK3-dependent astrocyte activation. These findings highlight a mechanism of neuron-glia crosstalk in which neuronal death perpetuates further neurodegeneration by engaging inflammatory astrocyte activation via RIPK3.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 28
- FWCI
- 4.18
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB
Tsui-Wen Chou, Nydia P. Chang, … Brian P. Daniels·Cell Death and DiseasePeer-reviewed·Jul 31, 2021
- PINK1/Parkin-dependent mitophagy mediates astrocytic inflammatory responses to mitochondrial damage
Julia F. Riley, Charity V Robbins, Erika L.F. Holzbaur·bioRxiv·May 13, 2026
- Immunosuppressive tocilizumab prevents astrocyte induced neurotoxicity in hiPSC-LRRK2 Parkinson's disease by targeting receptor interleukin-6
Meritxell Pons‐Espinal, Lucas Blasco-Agell, … Antonella Consiglio·JCI InsightPeer-reviewed·Feb 8, 2024
- The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease
Maritza Oñate, Alejandra Catenaccio, … Felipe A. Court·Cell Death and DifferentiationPeer-reviewed·Oct 7, 2019
- Exosomal miR-23a release coincides with astrocytic calcineurin activation, protects neurons from apoptosis by regulating NOXA in Parkinson's disease models and is enriched in the plasma of patients with Parkinson's disease
Pallabi Bhattacharyya, Kusumika Gharami, … Subhas Chandra Biswas·bioRxiv·Sep 15, 2026
- Pathologic α-Synuclein-NOD2 Interaction and RIPK2 Activation Drives Microglia-Induced Neuroinflammation in Parkinson's Disease
Bo Am Seo, Seung‐Hwan Kwon, … Han Seok Ko·bioRxiv·Feb 19, 2024